tm logo
TRANSEPI
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 15 Aug 2021

Last Applicant/ Owned by

196 West Ashland Street

Doylestown

PA

18901

Serial Number

85965343 filed on 20th Jun 2013

Registration Number

4625776 registered on 21st Oct 2014

in the Principal Register

Correspondent Address

Keith R. Lange

LANGE IP LAW

PO BOX 193

LINCOLN UNIVERSITY, PA 19352-0193

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TRANSEPI

TRANSDERMAL EPI A proprietary dermatological delivery system, namely, drug delivery formulations sold as an integral ingredient of pharmaceutical preparations for the topical and transdermal delivery of a wide range of cosmetic ingredients, namely, micronutrients, antioxidants and sun-protecting ingredients

Classification Information


Class [005]
Pharmaceutical Products


A proprietary dermatological delivery system, namely, drug delivery formulations sold as an integral ingredient of pharmaceutical preparations for the topical and transdermal delivery of a wide range of cosmetic ingredients, namely, micronutrients, antioxidants and sun-protecting ingredients


First Use Date in General

11th Jul 2014

First Use Date in Commerce

11th Jul 2014

Mark Details


Serial Number

No 85965343

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 9008.540

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Oct 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
15th Aug 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15th Aug 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
15th Aug 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20th Apr 2021TEAS SECTION 8 & 15 RECEIVED
21st Oct 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
21st Oct 2014REGISTERED-PRINCIPAL REGISTER
17th Sep 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Sep 2014SU-EXAMINER'S AMENDMENT WRITTEN
16th Sep 2014EXAMINERS AMENDMENT E-MAILED